Peptide therapy TikTok claims: what the science actually supports

What's this video probably claiming?

With hashtags like #peptidetherapy and #peptidepower, plus a medspa-affiliated creator directing viewers to Instagram stories for product details, this video is almost certainly running through a roster of injectable and oral peptides, framing them as accessible tools for recovery, body composition, anti-aging, or cognitive enhancement. Creators in this space typically present peptides like BPC-157, TB-500, CJC-1295, ipamorelin, and GHK-Cu as well-established therapeutics rather than experimental compounds. The implied message is usually that these products are safe, effective, and worth buying, often from the same account doing the promoting. What rarely gets mentioned: most of these peptides have zero FDA-approved clinical indications in the United States, and several have never completed a Phase III human trial.

What does the science actually show?

The honest answer is: it depends heavily on the specific peptide, and the evidence base varies wildly. BPC-157 has shown genuine promise in rodent models for gut healing and tendon repair, but as of 2024 there are no published randomized controlled trials in humans (Sikiric et al., 2018, Current Pharmaceutical Design). CJC-1295 combined with ipamorelin does produce measurable increases in growth hormone pulse amplitude, with one study showing a 2-10 fold increase in GH levels at doses of 1-2 mcg/kg (Teichman et al., 2006, Journal of Clinical Endocrinology and Metabolism), but long-term safety data is sparse. GHK-Cu has legitimate in-vitro evidence for collagen stimulation (Pickart et al., 2015, Journal of Aging Research), but topical versus injectable bioavailability comparisons are not well characterized. MK-677, an oral ghrelin mimetic, increased IGF-1 by roughly 40-60% in older adults over 12 months but also increased fasting glucose and water retention in the same trial (Nass et al., 2008, Annals of Internal Medicine).

Where does the social media noise diverge from clinical reality?

The gap is significant. Medspa-affiliated TikTok accounts routinely present animal data as functionally equivalent to human clinical evidence, which it is not. A peptide healing tendon tissue in rats under controlled lab conditions tells you something biologically interesting. It does not tell you that injecting a compounded version of that peptide will fix your shoulder. The FDA has specifically flagged BPC-157 as not meeting the criteria for compounding under 503A and 503B pharmacies, meaning any compounded BPC-157 being sold is operating in a legally gray area. TB-500, or Thymosin Beta-4, faces similar regulatory questions. Semax and Selank are Russian-developed peptides with some published human data from Eastern European journals, but those studies are difficult to evaluate for methodology quality. When a creator says these are "peptides we offer" without discussing regulatory status, mechanism uncertainty, or side effect profiles, that is a meaningful omission.

What should you actually know?

Peptide therapy is a legitimate and evolving area of medicine. Some peptides, like sermorelin, have actual FDA approval histories and documented safety profiles. Others in this category are being researched seriously at academic institutions. The problem is not that these compounds are worthless. The problem is the conflation of promising preclinical data with proven clinical utility, and the selling of compounded peptides without adequate informed consent about what is and is not known. If you are considering any of these compounds, the questions worth asking are: Has this been studied in humans at the dose and route being sold? What are the known adverse effects? Is the compounding pharmacy DEA-registered and third-party tested? And critically, does the person prescribing this have a genuine clinical rationale, or are they running a product list on Instagram stories?